Views & Analysis Ensuring access: how to help patients seeking experimental t... The impact of the debate on the Right-to-Try laws in the US and what needs to be done to improve access to innovative drugs.
Views & Analysis Going beyond CSR to reach ‘the two billion’ Impact of putting access to medicine at the core of pharma businesses.
News Novo sues Lilly over 'misleading' GLP-1 ad campaigning The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.